Clinical question: Is there a mortality difference between early transition to oral antibiotics versus prolonged intravenous antibiotics in uncomplicated gram-negative bacteremia? Background: Although ...
The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections (uUTIs). Orlynvah (sulopenem etzadroxil and probenecid) is a broad-spectrum ...
This is the first oral penem approved for use in the USA, and second FDA-approved treatment for uncomplicated urinary tract infections (uUTIs) in the past two decades, according to Iterum, which noted ...
The FDA on Friday signed off on Iterum Therapeutics’ oral antibiotic sulopenem etzadroxil and probenecid, which will now be marketed as Orlynvah, for the treatment of uncomplicated urinary tract ...
FDA accepted GSK's gepotidacin application for uUTI treatment with a PDUFA date set for March 26, 2025. Gepotidacin showed superior efficacy over nitrofurantoin in EAGLE-3 trial with a 58.5% ...
Logistic regression was used to estimate the odds ratios (OR) of switch to an oral regimen after 2 weeks. Results: Median antibiotic treatment was 8.1 weeks in 61 identified patients. Switch to ...
Investing in a powerful, effective oral rinse can help make a difference. Sami Clarke, a renowned celebrity trainer, is known for having glowing skin and a pretty smile. We found her favorite oral ...
Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Institute of Health Policy, Management ...
These openings in the skin can result from frequent nose blowing, picking the nose, or trimming nose hairs. Nasal vestibulitis is rarely severe, especially when treated with antibiotic cream or oral ...
ORLYNVAH™ is the first oral penem antibiotic to be approved in the U.S. and represents a new option for patients with limited or no alternative oral antibacterial treatments. The FDA's decision is ...
The FDA has approved a new oral antibiotic to treat uncomplicated urinary tract infections. Orylnvah is a broad-spectrum oral penem antibiotic for women who have limited or no alternative ...